Table 1.
ACOX2-i9 association to clinical parameters in a cohort of 113 breast cancer patients
| A | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Tumor grade | ER | PR | TP53 | |||||||
| N | 1 | 2 | 3 | Pos | Neg | Pos | Neg | WT | Mut | |
| ACOX2-i9 pos | 43 | 60 % | 51 % | 25 % | 43 % | 35 % | 46 % | 30 % | 49 % | 27.5 % |
| ACOX2-i9 neg | 62 | 40 % | 49 % | 75 % | 57 % | 65 % | 54 % | 70 % | 51 % | 72.5 % |
| p value | 0.015 | 0.52 | 0.14 | 0.04 | ||||||
ACOX2-i9 was detected (pos) or not detected (neg) by PCR assay and correlated with tumor grade, estrogen receptor (ER), progesterone receptor (PR), or TP53 mutational status. A Fisher exact test was used to determine P values for the likelihood of association